Danfeng Luo
Impact in
-
- Cancer-related molecular mechanisms research
-
- Peptidase Inhibition and Analysis
Papers in
- Oncology 10
- CAR-T cell therapy research 2
-
- Cancer-related molecular mechanisms research 2
- Co-authors
- Ding Ma (16 shared papers)Xiangyi Ma (14 shared papers)Jianfeng Zhou (9 shared papers)Wanhua Yang (6 shared papers)Ronghua Liu (5 shared papers)Rui Wei (7 shared papers)Gang Chen (2 shared papers)Shixuan Wang (4 shared papers)
- Journals
- Oncotarget (3 papers)Advanced Science (2 papers)Nanomedicine (1 paper)Theranostics (1 paper)Arthritis Research & Therapy (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Danfeng Luo
32 papers receiving 715 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 82
- Oncology 148
- Molecular Biology 301
- Immunology 89
- Biomaterials 56
Countries citing papers authored by Danfeng Luo
This map shows the geographic impact of Danfeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danfeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danfeng Luo more than expected).
Fields of papers citing papers by Danfeng Luo
This network shows the impact of papers produced by Danfeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danfeng Luo. The network helps show where Danfeng Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Danfeng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 102 | |
| 2 | 2019 | 46 | |
| 3 | 2021 | 45 | |
| 4 | 2017 | 43 | |
| 5 | 2023 | 41 | |
| 6 | 2012 | 38 | |
| 7 | 2017 | 38 | |
| 8 | 2014 | 34 | |
| 9 | 2012 | 32 | |
| 10 | 2021 | 30 | |
| 11 | 2021 | 28 | |
| 12 | 2024 | 25 | |
| 13 | 2016 | 25 | |
| 14 | 2019 | 22 | |
| 15 | 2013 | 20 | |
| 16 | 2009 | 19 | |
| 17 | 2012 | 18 | |
| 18 | 2024 | 15 | |
| 19 | 2017 | 15 | |
| 20 | 2018 | 10 |
About Danfeng Luo
Danfeng Luo is a scholar working on Oncology, Cancer Research, Molecular Biology, Obstetrics and Gynecology and Immunology, having authored 32 papers that have together received 720 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Advanced Nanomaterials in Catalysis (2 papers), Circular RNAs in diseases (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Ferroptosis and cancer prognosis (2 papers), Cancer-related molecular mechanisms research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Cancer Research (82 citations), Oncology (148 citations), Molecular Biology (301 citations), Immunology (89 citations) and Biomaterials (56 citations). Danfeng Luo has collaborated with scholars based in China and United States. Frequent co-authors include Ding Ma, Xiangyi Ma, Jianfeng Zhou, Wanhua Yang, Ronghua Liu, Rui Wei, Gang Chen, Shixuan Wang, Qinghua Zhang and Zhen Liu. Their work appears in journals such as Oncotarget, Advanced Science, Nanomedicine, Theranostics and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.